1994
DOI: 10.1002/jps.2600830307
|View full text |Cite
|
Sign up to set email alerts
|

Cetyl Myristoleate Isolated from Swiss Albino Mice: An Apparent Protective Agent against Adjuvant Arthritis in Rats

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1

Citation Types

0
23
0

Year Published

1999
1999
2022
2022

Publication Types

Select...
4
1

Relationship

0
5

Authors

Journals

citations
Cited by 25 publications
(23 citation statements)
references
References 1 publication
0
23
0
Order By: Relevance
“…
The proposed arthro-preventive action of cetyl myristoleate, an OTC product sold as a nutritional supplement, could not be confirmed, using an almost identical bioassay (adjuvant-induced polyarthritis in rats) as that described in the original report (Diehl and May, 1994) with the same, and 3 other, dosing schedules.
…”
mentioning
confidence: 62%
See 4 more Smart Citations
“…
The proposed arthro-preventive action of cetyl myristoleate, an OTC product sold as a nutritional supplement, could not be confirmed, using an almost identical bioassay (adjuvant-induced polyarthritis in rats) as that described in the original report (Diehl and May, 1994) with the same, and 3 other, dosing schedules.
…”
mentioning
confidence: 62%
“…(i) as a single dose dissolved in oil and injected s.c. 48 h before the arthritigen, the procedure described by Diehl and May (1994); (ii) prophylactically as an aqueous dispersion or olive oil solution given orally for 16 days beginning on the day before the arthritigen was injected; (iii) therapeutically given s.c. only after the first signs of arthritis were manifest (day 10) for 4 days only; (iv) co-administration with the arthritigen.…”
Section: Methodsmentioning
confidence: 99%
See 3 more Smart Citations